CAI logo

CAI
Caris Life Sciences Inc.

880
Mkt Cap
$5.05B
Volume
2.41M
52W High
$42.50
52W Low
$16.28
PE Ratio
-9.99
CAI Fundamentals
Price
$19.13
Prev Close
$17.88
Open
$18.89
50D MA
$20.53
Beta
0.67
Avg. Volume
2.73M
EPS (Annual)
-$1.90
P/B
9.36
Rev/Employee
$439,887.87
$7,250.15
Loading...
Loading...
News
all
press releases
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Consensus Recommendation of "Hold" from Analysts
Caris Life Sciences, Inc. (NASDAQ:CAI - Get Free Report) has been given a consensus recommendation of "Hold" by the five analysts that are currently covering the company, Marketbeat reports. One...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Why Is Caris Life Sciences Stock Gaining Wednesday?
Caris Life Sciences stock surges on positive Achieve 1 cancer test data. See key CAI levels and study results here.read more...
Benzinga·17h ago
News Placeholder
The Goldman Sachs Group Begins Coverage on Caris Life Sciences (NASDAQ:CAI)
The Goldman Sachs Group assumed coverage on Caris Life Sciences in a research note on Wednesday. They issued a "buy" rating and a $27.00 price target on the stock...
MarketBeat·18h ago
News Placeholder
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the...
PR Newswire·1d ago
News Placeholder
Zevenbergen Capital Investments LLC Takes $14.66 Million Position in Caris Life Sciences, Inc. $CAI
Zevenbergen Capital Investments LLC purchased a new position in shares of Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) in the 4th quarter, according to its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
Caris Life Sciences (NASDAQ:CAI) Hits New 1-Year Low - Here's Why
Caris Life Sciences (NASDAQ:CAI) Sets New 12-Month Low - Should You Sell...
MarketBeat·6d ago
News Placeholder
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer PR Newswire IRVING, Texas, March 26, 2026...
PR Newswire·7d ago
News Placeholder
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026 Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary...
PR Newswire·8d ago
News Placeholder
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal...
PR Newswire·9d ago
News Placeholder
JPMorgan Chase & Co. Reduces Holdings in Caris Life Sciences, Inc. $CAI
JPMorgan Chase & Co. lowered its position in Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 858,105 shares of the company's stock after selling 76,528 shares during the quarter. JPMorga...
MarketBeat·9d ago
<
1
2
...
>

Latest CAI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.